Previous 10 | Next 10 |
GreenLab Selects Ginkgo Enzyme Services to Develop Novel Enzyme That Breaks Down 'Forever Chemicals' PR Newswire GreenLab is creating an enzymatic solution — to be grown and scaled within corn plants — to degrade PFAS, often called "forever chemicals," a major he...
2023-12-16 13:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest stories of the year has been the rise of AI in every industry. This trend will hit biotech stocks no less than any others. Already, cutting edge healthcare stocks ...
Ginkgo Bioworks Receives Grant to Develop Innovative Live Cell Delivery Platform of Antibody Therapeutics for Treating HIV and Malaria PR Newswire Ginkgo, under a grant from the Bill & Melinda Gates Foundation, will work to develop a live cell therapeutic that can produce ...
2023-12-12 20:24:54 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value increased slightly to $24.64B, with 80 holdings. The largest positions in the portfolio are Visa, Workday, Amazon.com, United Parcel Service, and Danaher Corp. New stakes include Block Inc., Freep...
Arbor Biotechnologies Announces Collaboration with Ginkgo Bioworks to Advance the Discovery and Development of Precision Gene Editors PR Newswire Arbor, a biotechnology company discovering and developing the next generation of genetic medicines, will leverage Ginkgo's R&D ...
Agrivalle and Ginkgo Bioworks Enter Multiyear Strategic Partnership to Accelerate Next-Gen Ag Biological Products PR Newswire SÃO PAULO and BOSTON , Dec. 8, 2023 /PRNewswire/ -- Agrivalle, a leading Brazilian agricultural biologicals company, today announced...
2023-12-06 17:21:46 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks: A Long Way To Go Ginkgo Bioworks: More Revenue Issues Ginkgo Bioworks Holdings Inc. (DNA) Q3 2023 Earnings Call Transcript Ginkgo Bioworks stock sinks after Q3 earnings miss Gink...
Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan PR Newswire Synplogen, a synthetic biology startup spun out of Kobe University's Graduate School of Science, Technology and Innovation that provi...
2023-12-01 16:30:00 ET Ginkgo Bioworks (NYSE: DNA) went public a few years ago. With sky-high expectations for growth spanning multiple industries, it may have been tempting for investors to take a chance on the up-and-coming cell programming business. Investing $1,000 may have been...
2023-12-01 05:15:00 ET With the markets rallying, right now is the perfect time to think about stocks that could offer your portfolio a good deal of growth. These players may not soar overnight, but thanks to their innovative technologies, they could become future winners -- and significant...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
Ginkgo Bioworks Holdings Inc. Class A Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals PR Newswire Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland ...